Qubit Pharmaceuticals
FranceEntry
2022
Hold
4yr
Status
Active
Who owns Qubit Pharmaceuticals?
Qubit Pharmaceuticals is a French Biotech company, currently owned by Omnes Capital since 2022 and 3 other investors.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key takeaways
- ·Co-held by Audacia, Quantonation Ventures, Omnes Capital and XAnge since 2020.
- ·4 distinct PE sponsors across ownership cycles.
Ownership history
4 ownership periods · co-invest detected
Active
Co-invest · 4 holders · 2020 · present
AudaciaActive
2020 · present(6yr) · Quantonation I · 2018 · VC
Quantonation VenturesActive
2020 · present(6yr) · Quantonation I · 2019 · VC
XAngeActive
2022 · present(4yr) · XAnge 04 · 2021 · VC
Omnes CapitalActive
2022 · present(4yr) · Omnes Real Tech 1 · 2018 · VC
More from XAnge 04
Other portfolio companies in the same fund.
Germany
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Qubit Pharmaceuticals?
Qubit Pharmaceuticals is currently owned by Omnes Capital, XAnge and 2 others, through XAnge 04, since 2022.
When did Omnes Capital and 3 others acquire Qubit Pharmaceuticals?
Omnes Capital and 3 others acquired Qubit Pharmaceuticals in 2022.
Who has owned Qubit Pharmaceuticals over time?
Qubit Pharmaceuticals has been through 4 private-equity ownership periods: Audacia · via Quantonation I · since 2020; Quantonation Ventures · via Quantonation I · since 2020; Omnes Capital · via Omnes Real Tech 1 · since 2022; XAnge · via XAnge 04 · since 2022.
Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue